1404.1000 12.50 (0.90%)
NSE Dec 18, 2025 11:46 AM
Volume: 52,095
 

1404.10
0.90%
ICICI Securities Limited
Tatva Chintan’s Q2FY23 revenue fell 27.1% YoY and EBITDA plunged 68.9% YoY due
to lower SDA sales, which seems very disappointing, but we believe this situation is
transitory.
Tatva Chintan Pharma Chem Ltd.'s price crossed below 50Day SMA today
More from Tatva Chintan Pharma Chem Ltd.
Recommended